Centre Hospitalier Universitaire (CHU)

Bordeaux

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Mantle Cell Lymphoma

Studies at this site

• Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) — Completed